Parallax Volatility Advisers, L.P. Sorrento Therapeutics, Inc. Call Options Transaction History

Parallax Volatility Advisers, L.P.

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Feb 14, 2022	SELL	$4.65 - $7.23 $73,470 - $114,234	-15,800 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$4.65 - $7.23 $544,980 - $847,356	-117,200 Reduced 88.12%	15,800 $73,000
Q4 2020 Feb 16, 2021	BUY	$5.76 - $11.95 $766,080 - $1.59 Million	133,000 New	133,000 $908,000
Q4 2020 Feb 16, 2021	SELL	$5.76 - $11.95 $766,080 - $1.59 Million	-133,000 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$6.17 - $18.82 $820,610 - $2.5 Million	133,000 New	133,000 $1.48 Million

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.